Cipla can sell generic version of Bayer’s cancer drug

2009 August 19

by Bhaskar

Cipla can sell generic version of Bayer’s cancer drug, rules HC

Cipla can sell generic version of Bayer’s cancer drug, rules HC. The Delhi HC orders Bayer to pay Rs 6.15 lakh to government and Cipla.

Bayer holds patent in India for anti-cancer drug Nexavar.

Your Ad Here

No related posts.

Comments are closed for this entry.

This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 2.5 India License

Vigilance Theme by Jestro

DISCLAIMER : Stock trading involves high risk and one can lose Substantial amount of money.The recommendations made herein Do not constitute an offer to sell or solicitation to buy any of the Securities mentioned. No representations can be made that recommendations contained herein will be profitable or they will Not result in losses. Readers using the information contained herein are solely responsible for their actions. The information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on technical analysis only.

News about Indian Stock Markets

Cipla can sell generic version of Bayer’s cancer drug

Recent Posts

Categories

Archives

Search

Authors

What I'm Doing...